Ther­mo Fish­er ex­pands in­to Switzer­land as part of CSL col­lab­o­ra­tion

Just days af­ter Ther­mo Fish­er Sci­en­tif­ic prepped to ex­pand a St. Louis plant, the com­pa­ny an­nounced it’s tak­ing over a new, 1.5 mil­lion-square-foot site in Switzer­land with plans to add 200 new em­ploy­ees.

The move is a part of a May 2020 part­ner­ship with CSL and the site, slat­ed to be com­plet­ed by next year, will first be used to man­u­fac­ture CSL’s re­com­bi­nant fac­tor IX prod­uct Idelvion, a treat­ment for he­mo­phil­ia B, with more treat­ments to be made there in the fu­ture.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.